Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Sol-Gel Technologies Ltd. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
SLGL
Nasdaq
2834
www.sol-gel.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Sol-Gel Technologies Ltd.
Is Sol-Gel Technologies (NASDAQ:SLGL) In A Good Position To Deliver On Growth Plans?
- Feb 7th, 2025 10:19 am
SolGel Technologies (SLGL) Upgraded to Buy: Here's What You Should Know
- Nov 20th, 2024 5:00 pm
Sol-Gel Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement
- Nov 20th, 2024 12:00 pm
Sol-Gel Technologies Third Quarter 2024 Earnings: Beats Expectations
- Nov 17th, 2024 1:56 pm
Sol-Gel Technologies Ltd. (SLGL) Reports Q3 Loss, Tops Revenue Estimates
- Nov 15th, 2024 1:10 pm
Sol-Gel Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
- Nov 15th, 2024 12:00 pm
SolGel Technologies (SLGL) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
- Sep 17th, 2024 1:55 pm
All You Need to Know About SolGel Technologies (SLGL) Rating Upgrade to Strong Buy
- Aug 27th, 2024 4:00 pm
Sol-Gel Technologies Second Quarter 2024 Earnings: Beats Expectations
- Aug 19th, 2024 10:25 am
UPDATE: Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
- Aug 17th, 2024 3:27 pm
Sol-Gel Technologies Ltd. (SLGL) Surpasses Q2 Earnings and Revenue Estimates
- Aug 16th, 2024 12:10 pm
Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
- Aug 16th, 2024 11:00 am
Sol-Gel Announces the Signing of Six Exclusive License Agreements to Commercialize TWYNEO® and EPSOLAY® in Europe and South Africa
- Jul 25th, 2024 11:00 am
Sol-Gel Technologies Announces Management Realignment
- Jul 15th, 2024 11:00 am
We're A Little Worried About Sol-Gel Technologies' (NASDAQ:SLGL) Cash Burn Rate
- Jun 3rd, 2024 11:42 am
Sol-Gel Announces Receipt of Nasdaq Minimum Price Notice
- May 28th, 2024 11:00 am
Sol-Gel Technologies Ltd. (SLGL) Reports Q1 Loss, Lags Revenue Estimates
- May 20th, 2024 12:10 pm
Sol-Gel Reports First Quarter 2024 Financial Results and Provides Corporate Updates
- May 20th, 2024 11:00 am
Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to Commercialize TWYNEO® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel
- May 16th, 2024 10:00 am
Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream
- Apr 1st, 2024 11:00 am
Scroll